Volume 11, Issue 1

Critical Review and Analysis of Approval of Favipiravir for Restricted Emergency Use in Mild-to-Moderate COVID-19

Arunkumar Radhakrishnan, Ruckmani Arunachalam, Abinaya Elango

pp. 1–7 · DOI: 10.4103/jpp.JPP_105_20 · Published 12 September 2020

The Central Drugs Standard Control Organization, the Indian drug regulatory agency, granted accelerated approval to Glenmark Pharmaceuticals to market favipiravir in mild-to-moderate COVID-19 on June 19, 2020, for restri…

Ubrogepant: The First Gepant to Pass Food and Drug Administration for Acute Migraine

Sivagourounadin Kiruthika, Rajendran Priyadharsini

pp. 33–34 · DOI: 10.4103/jpp.JPP_3_20 · Published 12 September 2020

Migraine is one of the most common and disabling forms of primary headache disorders. It is characterized by the presence of unilateral pulsatile headache associated commonly with nausea, vomiting, photophobia, and phono…

The Effects of a Single Preanesthetic dose of Dexmedetomidine on Propofol Induction, Hemodynamics, and Cardiovascular Parameters

Padmini Vishwanath, Rammoorthi Rao, Sunil Baikadi Vasudevarao

pp. 8–12 · DOI: 10.4103/jpp.JPP_91_19 · Published 12 September 2020

Objective: To find out the dose of propofol consumption for induction and also the variation in hemodynamics following single-dose dexmedetomidine premedication. Methods: A total of 60 American Society of Anesthesiologis…

Effect of Nebivolol on Microalbuminuria in Hypertensive Patients with or without Type 2 Diabetes Mellitus

Padma Latha Merugu, Thrilok Chander Bingi

pp. 13–18 · DOI: 10.4103/jpp.JPP_95_19 · Published 12 September 2020

Objective: To evaluate the effect of nebivolol on microalbuminuria (MA) in hypertensive patients with or without type 2 diabetes mellitus. Materials and Methods: This was an open-label, prospective study. Drug naive pati…

Evaluation of the Effect of Temperature on the Potency of Isophane Insulin in a Rat Model

Deepasree Sukumaran, Aruldhas Blessed Winston, Margaret Shanthi, Aniket Kumar

pp. 25–27 · DOI: 10.4103/jpp.JPP_9_20 · Published 12 September 2020

A Rare Toxicity to Chemotherapy

Dilip Harindran Vallathol, Neeharika Alapati, Sailaja Kagita, Raghunadharao Digumarti

pp. 28–29 · DOI: 10.4103/jpp.JPP_112_19 · Published 12 September 2020

The use of chemotherapy is often limited by toxic side-effects caused to healthy cells. In general, most chemotherapy treatments cause DNA damage or stop cells in mitosis, targeting both cancer and healthy cells. Life-th…

Ecthyma gangrenosum-Source Reduction along with Empirical Antibiotics and Wound Care Helps to Treat Serious Infections

A. Ramya, M. Manoj Kumar Raja, E. Bhavya, Vivekananadan K

pp. 30–32 · DOI: 10.4103/jpp.JPP_122_19 · Published 12 September 2020

Ecthyma gangrenosum (Eg) is a cutaneous necrotic lesion that is mostly seen in immunocompromised patients. It reflects a severe sepsis, possibly caused by Pseudomonas aeruginosa, an aerobic Gram-negative opportunistic pa…